Canada markets closed

Enzo Biochem, Inc. (ENZ)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
1.0900-0.0200 (-1.80%)
At close: 04:00PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-07-31
2022-07-31
2021-07-31
2020-07-31
Cash flows from operating activities
Net Income
32,566
20,288
-18,261
7,875
-28,520
Depreciation & amortization
1,791
2,682
2,827
2,653
2,780
Stock based compensation
3,505
3,148
2,339
1,638
1,769
Change in working capital
-1,711
18,558
-6,835
-4,774
7,957
Accounts receivable
5,632
5,033
-1,299
-1,110
1,617
Inventory
168
-334
-2,736
-4,937
85
Accounts Payable
-10,616
1,159
390
-395
1,214
Other working capital
-45,915
-39,736
-20,062
-4,049
-19,349
Other non-cash items
-
-81,807
-
-
-
Net cash provided by operating activites
-44,397
-36,976
-16,590
387
-17,179
Cash flows from investing activities
Investments in property, plant and equipment
-1,518
-2,760
-3,472
-4,436
-2,170
Purchases of investments
-
-
-
-30,061
0
Sales/Maturities of investments
-
0
28,695
-
-
Net cash used for investing activites
100,222
98,980
25,223
-34,497
-2,170
Cash flows from financing activities
Debt repayment
-24,898
-24,982
-269
-339
-411
Common stock issued
-
386
0
-
-
Other financing activites
-
-389
-
-
-
Net cash used privided by (used for) financing activities
-1,508
-1,125
-241
-242
7,001
Net change in cash
54,187
60,770
8,329
-34,341
-12,281
Cash at beginning of period
6,054
22,603
14,274
48,615
60,896
Cash at end of period
60,371
83,373
22,603
14,274
48,615
Free Cash Flow
Operating Cash Flow
-44,397
-36,976
-16,590
387
-17,179
Capital Expenditure
-1,518
-2,760
-3,472
-4,436
-2,170
Free Cash Flow
-45,915
-39,736
-20,062
-4,049
-19,349